Reduction of ARNT in myeloid cells causes immune suppression and delayed wound healing

Am J Physiol Cell Physiol. 2014 Aug 15;307(4):C349-57. doi: 10.1152/ajpcell.00306.2013. Epub 2014 Jul 2.

Abstract

Aryl hydrocarbon receptor nuclear translocator (ARNT) is a transcription factor that binds to partners to mediate responses to environmental signals. To investigate its role in the innate immune system, floxed ARNT mice were bred with lysozyme M-Cre recombinase animals to generate lysozyme M-ARNT (LAR) mice with reduced ARNT expression. Myeloid cells of LAR mice had altered mRNA expression and delayed wound healing. Interestingly, when the animals were rendered diabetic, the difference in wound healing between the LAR mice and their littermate controls was no longer present, suggesting that decreased myeloid cell ARNT function may be an important factor in impaired wound healing in diabetes. Deferoxamine (DFO) improves wound healing by increasing hypoxia-inducible factors, which require ARNT for function. DFO was not effective in wounds of LAR mice, again suggesting that myeloid cells are important for normal wound healing and for the full benefit of DFO. These findings suggest that myeloid ARNT is important for immune function and wound healing. Increasing ARNT and, more specifically, myeloid ARNT may be a therapeutic strategy to improve wound healing.

Keywords: aryl hydrocarbon receptor nuclear translocator; deferoxamine; hypoxia-inducible factor-1α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Animals
  • Aryl Hydrocarbon Receptor Nuclear Translocator / deficiency*
  • Aryl Hydrocarbon Receptor Nuclear Translocator / genetics
  • Aryl Hydrocarbon Receptor Nuclear Translocator / metabolism*
  • Case-Control Studies
  • Cells, Cultured
  • Cytokines / genetics
  • Cytokines / metabolism
  • Deferoxamine / pharmacology
  • Dermatitis / genetics
  • Dermatitis / immunology
  • Dermatitis / metabolism
  • Dermatitis / pathology
  • Diabetes Complications / genetics
  • Diabetes Complications / immunology
  • Diabetes Complications / metabolism
  • Diabetes Complications / pathology
  • Diabetes Mellitus, Experimental / genetics
  • Diabetes Mellitus, Experimental / immunology
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / pathology
  • Female
  • Gene Expression Regulation
  • Genotype
  • Graft Survival
  • Humans
  • Immunity, Innate* / genetics
  • Immunocompromised Host* / genetics
  • Inflammation Mediators / metabolism
  • Integrases / genetics
  • Macrophage Activation
  • Macrophages / immunology
  • Macrophages / metabolism
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Middle Aged
  • Monocytes / immunology
  • Monocytes / metabolism
  • Muramidase / genetics
  • Myeloid Cells / drug effects
  • Myeloid Cells / immunology
  • Myeloid Cells / metabolism*
  • Phenotype
  • RNA, Messenger / metabolism
  • Skin / immunology
  • Skin / metabolism
  • Skin / pathology
  • Skin Transplantation
  • Time Factors
  • Transplantation Tolerance* / genetics
  • Wound Healing* / drug effects
  • Wound Healing* / genetics

Substances

  • ARNT protein, human
  • Arnt protein, mouse
  • Cytokines
  • Inflammation Mediators
  • RNA, Messenger
  • Aryl Hydrocarbon Receptor Nuclear Translocator
  • Cre recombinase
  • Integrases
  • Muramidase
  • Deferoxamine